Biogen (BIIB)

Company Ticker Sector | Industry Quality PAR
Biogen BIIB Healthcare | Drug Manufacturers - General 76 13.1%
Current Price (11/24) $242.51
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 14,263.3
Sales Growth Forecast 4.0%
Net Profit Margin 27.8%
Projected Shares Outstanding 140.00
EPS - Five year Forecast $34.48
Average P/E Ratio 13.0
Projected Average Price $448.26
Price Appreciation (Annualized) 13.1%
Annual Dividend Yield 0.0%
Projected Annual Return 13.1%
Quality
Financial Strength 68 17.0
EPS Stability 84 21.0
Industry Sales Growth Rate 8.0% 6.3
Industry Net Profit Margin 22.5% 15.4
Calculated Quality Rating 59.6
Fool CAPS

Total Players

979 Outperforms
72 Underperforms
 

All-Stars (227)

213 Outperforms (94%)
14 Underperforms
 
Fundamental Data Updated: 10/02/2020

MIPAR 5.7%  
Sweet Spot 10.7% - 15.7%  

Top In Drug Manufacturers - General

Ticker Quality PAR
MRK 92 10.6%
BMY 91 10.5%
AMGN 95 8.3%
BIIB 76 13.1%
JNJ 91 8.2%

Top In Healthcare

Ticker Quality PAR
CMD 83 13.7%
MRK 92 10.6%
ADUS 80 13.5%
BMY 91 10.5%
ABC 88 10.9%